ENZYRE
ENZYRE
Social Links:
Industry:
Health Care Medical Device
Founded:
2016-01-01
Address:
Nijmegen, Gelderland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.enzyre.com
Total Employee:
11+
Status:
Active
Contact:
31 0 24 6690036
Total Funding:
1.4 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Investors List
Novalis Biotechnology Incubation
Novalis Biotechnology Incubation investment in Debt Financing - Enzyre
Official Site Inspections
http://www.enzyre.com Semrush global rank: 5.18 M Semrush visits lastest month: 1.56 K
- Host name: linux91.webawere.nl
- IP address: 185.158.167.226
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Enzyre"
About us - Enzyre
Enzyre is always looking for collaborations to expand use of its platform technologies. Interested parties are encouraged to contact us at [email protected]. Get involved. Get in touch +31 โฆSee details»
Enzyre - Crunchbase Company Profile & Funding
Organization. Enzyre . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Enzyre is a developer of diagnostic technology. ...See details»
Technology - Enzyre
Enzyre is always looking for collaborations to expand use of its platform technologies. Interested parties are encouraged to contact us at [email protected]. Get involved. Get in touch +31 (0)24 6690036; โฆSee details»
Enzyre Company Profile 2024: Valuation, Funding & Investors
Enzyre General Information Description. Developer of an ambulant diagnostic technology designed to bring the lab to the patient and improve the quality of life without increasing โฆSee details»
Enzyre - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 2, 2022: Series A - Enzyre โฆSee details»
Enzyre Company Information - Funding, Investors, and More
Enzyre Unknown (2022, $11M) $11.78m. Discover Enzyre. Company size. 11 - 51. Funding Rounds. 2. Investors. 2. Money raised. 23.58m. Seedtable tracks the fastest growing โฆSee details»
Enzyre Company Profile - Office Locations, Competitors, Revenue โฆ
Enzyre is a diagnostic technology company. It develops a near-patient test (NPT) device named Enzypad to measure biomarkers in body fluids. The company can monitor hemophilia by โฆSee details»
Enzyre - Contacts, Employees, Board Members, Advisors & Alumni โฆ
Organization. Enzyre . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Enzyre has 2 โฆSee details»
Enzyre - Products, Competitors, Financials, Employees, โฆ
Enzyre. Frequently Asked Questions (FAQ) When was Enzyre founded? Enzyre was founded in 2016. Where is Enzyre's headquarters? Enzyre's headquarters is located at Transistorweg 5, โฆSee details»
Contact - Enzyre
[email protected]. General inquiries. [email protected] +31 (0)24 6690036; Job Opportunities. [email protected]. Get in touch +31 (0)24 6690036; [email protected]; Where to โฆSee details»
Enzyre - Company Profile - Tracxn
Nov 19, 2024 Enzyre ranks 3rd among 30 active competitors. 8 of its competitors are funded while 5 have exited. Overall, Enzyre and its competitors have raised over $226M in funding โฆSee details»
Enzyre - EU-Startups
Enzyre is a developer of diagnostic technology. The ENZYPAD enables real near patient blood coagulation analysis, with the measured data being effortlessly made available to the treating โฆSee details»
i&i Biotech Fund invests more than โฌ1 Million in Enzyre to help to ...
Feb 11, 2022 Enzyre, a company developing a breakthrough ambulant diagnostic technology for blood coagulation testing, today announced that it has successfully raised EUR 12 million โฆSee details»
Enzyre Announces Founder and CEOโs Transition
Nijmegen, November 1, 2023 โ Enzyre, a startup company focused on blood coagulation management by developing point-of-care IVD solutions, announces a significant change in its โฆSee details»
Enzyre closes Series A financing round of โฌ12M - Radboudumc
Nov 2, 2022 Email: [email protected]. About Enzyre . Enzyre is a spin-out from Radboud University Medical Center in The Netherlands founded by Waander van Heerde and โฆSee details»
Enzyre - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Enzyre . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. ... This year, Enzyre is โฆSee details»
Revolutionizing Personalized Diagnostics with Enzyre's โฆ
Discover how Enzyre, in collaboration with the Microfluidics Innovation Hub, is transforming personalized diagnostics. Enzyre's innovative chemiluminescent microfluidic platform, the โฆSee details»
News - Enzyre
May 4, 2022 Enzyre announces strategic partnership with Takeda to accelerate development of pioneering diagnostic technology platform for hemophilia patients . January 6, 2021. Enzyre โฆSee details»
Enzyre wins Best Blood Coagulation Analysis Product 2020 award!
Jan 6, 2021 Enzyreโs Enzypad technology was recognised by Global Health and Pharma as Best Blood Coagulation Analysis Product 2020. We are happy that the potential of the โฆSee details»